Abstract: An electromechanical motor vehicle power steering system having a multiphase, permanently excited electric motor via a controller and supply lines from an onboard power supply of a motor vehicle.

Abstract: The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.

Abstract: Techniques for capturing spoken user inputs while a device is prevented from capturing such spoken user inputs are described. When a first device becomes incapable of capturing spoken user inputs intended for a system, a second device, for capturing such spoken user inputs, may be identified. The second device may be identified based on the second device being connected to a same vehicle computing system as the first device. The second device may be enabled to capture spoken user inputs, intended for the system, until the first device is again able to capture such spoken user inputs.

Abstract: Techniques for capturing spoken user inputs while a device is prevented from capturing such spoken user inputs are described. When a first device has a status representing it is unbeneficial for the first device to perform wakeword detection, a second device (e.g. a vehicle) may perform wakeword detection on behalf of the first device. The second device may be unable to send audio data, representing a spoken user input, to a speech processing system. In such an example, the second device may send the audio data to a third device, which may send the audio data to the speech processing system.

Abstract: The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.

Abstract: Methods and systems providing for the generation, sending, updating, and monitoring of electronic documents (eDocuments) based on source documents created in Enterprise Resource Planning (ERP) software. An eDocument is generated based on existing source documents, external data, or from other eDocuments. The method and systems ensure that the generated eDocument is compliant with any technical requirements. The eDocument is generated using a document process which transforms a non-compliant source document into a compliant eDocument. An eDocument Framework system can include a mapping application, application interface framework (AIF), an eDocument interface, and a process manager. The AIF is configured to interact with a cloud services provider to create a highly automated process of generating, sending, updating, and monitoring the eDocuments. The cloud service provider is also configured to interact with local authorities.

Abstract: A cross-neutralizing monoclonal antibody that specifically recognizes a cross-reactive epitope of the lipopolysaccharide (LPS) antigen structure of Klebsiella pneumoniae, which is an O3b epitope, cross-reacting with an O3a epitope and an O3 epitope, wherein the antibody is characterized by specific CDR sequences or VH and VL sequences.

Abstract: A cross-neutralizing monoclonal antibody that specifically recognizes a cross-reactive epitope of the lipopolysaccharide (LPS) antigen structure of Klebsiella pneumoniae, which is an O3b epitope, cross-reacting with an O3a epitope and an O3 epitope, wherein the antibody is characterized by specific CDR sequences or VH and VL sequences.

Abstract: Techniques for capturing spoken user inputs while a device is prevented from capturing such spoken user inputs are described. When a first device has a status representing it is unbeneficial for the first device to perform wakeword detection, a second device (e.g. a vehicle) may perform wakeword detection on behalf of the first device. The second device may be unable to send audio data, representing a spoken user input, to a speech processing system. In such an example, the second device may send the audio data to a third device, which may send the audio data to the speech processing system.

Abstract: Techniques for capturing spoken user inputs while a device is prevented from capturing such spoken user inputs are described. When a first device becomes incapable of capturing spoken user inputs intended for a system, a second device, for capturing such spoken user inputs, may be identified. The second device may be identified based on the second device being connected to a same vehicle computing system as the first device. The second device may be enabled to capture spoken user inputs, intended for the system, until the first device is again able to capture such spoken user inputs.

Abstract: A cross-neutralizing monoclonal antibody that specifically recognizes a cross-reactive epitope of the lipopolysaccharide (LPS) antigen structure of Klebsiella pneumoniae, which is an O3b epitope, cross-reacting with an O3a epitope and an O3 epitope, wherein the antibody is characterized by specific CDR sequences or VH and VL sequences.

Abstract: A cross-neutralizing monoclonal antibody that specifically recognizes a cross-reactive epitope of the lipopolysaccharide (LPS) antigen structure of Klebsiella pneumoniae, which is an O3b epitope, cross-reacting with an O3a epitope and an O3 epitope, wherein the antibody is characterized by specific CDR sequences or VH and VL sequences.

Abstract: The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.

Abstract: The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.

Abstract: The invention provides for an isolated antibody that specifically recognizes an epitope of the lipopolysaccharide (LPS) O3b-antigen structure of Klebsiella pneumoniae, which is a O3b-epitope incorporated in O3b-antigen comprising the structure of Formula (I), including one or more O3b-antigen mannose homopolymer repeating units, wherein Formula (I) is: MeP?3)-?-D-Manp-(1?2)-?-D-Manp-(1?3)-?-D-Manp-(1?[3)-?-D-Manp-(1?2)-?-D-Manp-(1?3)-?-D-Manp-(1?]n wherein MeP is methyl phosphate; and n is 0-50. The invention further provides for a pharmaceutical or diagnostic preparation comprising said antibody, and a method of producing said antibody.

Abstract: A human or humanized monoclonal IgG antibody (mAb) specifically recognizing the D-galactan-II antigen of Klebsiella pneumoniae O1 which is characterized by a bactericidal CDC activity, its method of production, medical and diagnostic use.

Abstract: The subject relates to a cross-neutralizing antibody comprising at least one polyspecific binding site that binds to alpha-toxin (Hla) and at least one of the bi-component toxins of Staphylococcus aureus, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated conformational epitope recognized by a specific cross-neutralizing antibody.

Abstract: The invention provides for an isolated antibody that specifically recognizes a galactan-III epitope of the lipopolysaccharide (LPS) O-antigen structure of Klebsiella pneumoniae , which epitope is incorporated in galactan-III repeating units, wherein the galactan-III repeating unit is a branched galactose homopolymer of Formula (I). The invention further provides for a pharmaceutical or diagnostic preparation comprising said antibody, and a method of producing said antibody.

Abstract: A motion transfer apparatus comprising a frame; at least one wheel shaft operably coupled to at least one wheel, the at least one wheel shaft rotatable on the frame; a gear assembly coupled to the at least one wheel shaft; at least one pedal engaging the gear assembly and movable by an appendage within a predetermined angular range to apply a force; at least one crank arm with a predetermined length coupled to the at least one pedal and to the gear assembly for applying the force directly from the pedal to the gear assembly to rotate the at least one wheel; and a restorative member generating a restorative force to return the pedal and the at least one crank arm from a lower stroke position to an upper stroke position.